<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 19 May 2026 05:30:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem</title>
   <link>http://www.streetinsider.com/Press+Releases/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;Three companies with strong roots in the state are revolutionizing the treatment of cardiovascular disease through hydraulic lithotripsy technology&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    CHARLEVOIX, Mich.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.biostarcapital.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=BioStar+Capital&amp;amp;index=1&amp;amp;md5=e4ed4965cb14de744aeaa525f6c4a087&quot; shape=&quot;rect&quot;&gt;BioStar Capital&lt;/a&gt;, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.avspulse.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Amplitude+Vascular+Systems%2C+Inc.&amp;amp;index=2&amp;amp;md5=c8cae98c80cbfdedb6668995e52b1956&quot; shape=&quot;rect&quot;&gt;Amplitude Vascular Systems, Inc.&lt;/a&gt; (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.stryker.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Stryker&amp;amp;index=3&amp;amp;md5=434f1fb06ba1f087723ea7805934df44&quot; shape=&quot;rect&quot;&gt;Stryker&lt;/a&gt; (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</guid>
   <pubDate>Tue, 19 May 2026 05:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04464118</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216461</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60005111</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02855423</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04998225</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13601934</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13804794</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYK</category>
   	  </item>
  <item>
   <title>BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem</title>
   <link>http://www.streetinsider.com/Press+Releases/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;Three companies with strong roots in the state are revolutionizing the treatment of cardiovascular disease through hydraulic lithotripsy technology&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    CHARLEVOIX, Mich.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.biostarcapital.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=BioStar+Capital&amp;amp;index=1&amp;amp;md5=e4ed4965cb14de744aeaa525f6c4a087&quot; shape=&quot;rect&quot;&gt;BioStar Capital&lt;/a&gt;, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.avspulse.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Amplitude+Vascular+Systems%2C+Inc.&amp;amp;index=2&amp;amp;md5=c8cae98c80cbfdedb6668995e52b1956&quot; shape=&quot;rect&quot;&gt;Amplitude Vascular Systems, Inc.&lt;/a&gt; (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.stryker.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Stryker&amp;amp;index=3&amp;amp;md5=434f1fb06ba1f087723ea7805934df44&quot; shape=&quot;rect&quot;&gt;Stryker&lt;/a&gt; (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</guid>
   <pubDate>Tue, 19 May 2026 05:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04464118</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216461</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60005111</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02855423</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04998225</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13601934</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13804794</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYK</category>
   	  </item>
  <item>
   <title>BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem</title>
   <link>http://www.streetinsider.com/Press+Releases/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;Three companies with strong roots in the state are revolutionizing the treatment of cardiovascular disease through hydraulic lithotripsy technology&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    CHARLEVOIX, Mich.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.biostarcapital.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=BioStar+Capital&amp;amp;index=1&amp;amp;md5=e4ed4965cb14de744aeaa525f6c4a087&quot; shape=&quot;rect&quot;&gt;BioStar Capital&lt;/a&gt;, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.avspulse.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Amplitude+Vascular+Systems%2C+Inc.&amp;amp;index=2&amp;amp;md5=c8cae98c80cbfdedb6668995e52b1956&quot; shape=&quot;rect&quot;&gt;Amplitude Vascular Systems, Inc.&lt;/a&gt; (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.stryker.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Stryker&amp;amp;index=3&amp;amp;md5=434f1fb06ba1f087723ea7805934df44&quot; shape=&quot;rect&quot;&gt;Stryker&lt;/a&gt; (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</guid>
   <pubDate>Tue, 19 May 2026 05:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04464118</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216461</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60005111</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02855423</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04998225</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13601934</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13804794</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYK</category>
   	  </item>
  <item>
   <title>BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem</title>
   <link>http://www.streetinsider.com/Press+Releases/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;Three companies with strong roots in the state are revolutionizing the treatment of cardiovascular disease through hydraulic lithotripsy technology&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    CHARLEVOIX, Mich.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.biostarcapital.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=BioStar+Capital&amp;amp;index=1&amp;amp;md5=e4ed4965cb14de744aeaa525f6c4a087&quot; shape=&quot;rect&quot;&gt;BioStar Capital&lt;/a&gt;, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.avspulse.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Amplitude+Vascular+Systems%2C+Inc.&amp;amp;index=2&amp;amp;md5=c8cae98c80cbfdedb6668995e52b1956&quot; shape=&quot;rect&quot;&gt;Amplitude Vascular Systems, Inc.&lt;/a&gt; (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.stryker.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Stryker&amp;amp;index=3&amp;amp;md5=434f1fb06ba1f087723ea7805934df44&quot; shape=&quot;rect&quot;&gt;Stryker&lt;/a&gt; (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</guid>
   <pubDate>Tue, 19 May 2026 05:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04464118</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216461</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60005111</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02855423</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04998225</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13601934</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13804794</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYK</category>
   	  </item>
  <item>
   <title>BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem</title>
   <link>http://www.streetinsider.com/Press+Releases/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;Three companies with strong roots in the state are revolutionizing the treatment of cardiovascular disease through hydraulic lithotripsy technology&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    CHARLEVOIX, Mich.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.biostarcapital.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=BioStar+Capital&amp;amp;index=1&amp;amp;md5=e4ed4965cb14de744aeaa525f6c4a087&quot; shape=&quot;rect&quot;&gt;BioStar Capital&lt;/a&gt;, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.avspulse.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Amplitude+Vascular+Systems%2C+Inc.&amp;amp;index=2&amp;amp;md5=c8cae98c80cbfdedb6668995e52b1956&quot; shape=&quot;rect&quot;&gt;Amplitude Vascular Systems, Inc.&lt;/a&gt; (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.stryker.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Stryker&amp;amp;index=3&amp;amp;md5=434f1fb06ba1f087723ea7805934df44&quot; shape=&quot;rect&quot;&gt;Stryker&lt;/a&gt; (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</guid>
   <pubDate>Tue, 19 May 2026 05:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04464118</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216461</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60005111</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02855423</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04998225</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13601934</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13804794</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYK</category>
   	  </item>
  <item>
   <title>BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem</title>
   <link>http://www.streetinsider.com/Press+Releases/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;Three companies with strong roots in the state are revolutionizing the treatment of cardiovascular disease through hydraulic lithotripsy technology&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    CHARLEVOIX, Mich.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.biostarcapital.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=BioStar+Capital&amp;amp;index=1&amp;amp;md5=e4ed4965cb14de744aeaa525f6c4a087&quot; shape=&quot;rect&quot;&gt;BioStar Capital&lt;/a&gt;, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.avspulse.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Amplitude+Vascular+Systems%2C+Inc.&amp;amp;index=2&amp;amp;md5=c8cae98c80cbfdedb6668995e52b1956&quot; shape=&quot;rect&quot;&gt;Amplitude Vascular Systems, Inc.&lt;/a&gt; (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.stryker.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Stryker&amp;amp;index=3&amp;amp;md5=434f1fb06ba1f087723ea7805934df44&quot; shape=&quot;rect&quot;&gt;Stryker&lt;/a&gt; (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</guid>
   <pubDate>Tue, 19 May 2026 05:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04464118</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216461</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60005111</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02855423</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04998225</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13601934</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13804794</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYK</category>
   	  </item>
  <item>
   <title>BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem</title>
   <link>http://www.streetinsider.com/Press+Releases/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;Three companies with strong roots in the state are revolutionizing the treatment of cardiovascular disease through hydraulic lithotripsy technology&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    CHARLEVOIX, Mich.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.biostarcapital.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=BioStar+Capital&amp;amp;index=1&amp;amp;md5=e4ed4965cb14de744aeaa525f6c4a087&quot; shape=&quot;rect&quot;&gt;BioStar Capital&lt;/a&gt;, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.avspulse.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Amplitude+Vascular+Systems%2C+Inc.&amp;amp;index=2&amp;amp;md5=c8cae98c80cbfdedb6668995e52b1956&quot; shape=&quot;rect&quot;&gt;Amplitude Vascular Systems, Inc.&lt;/a&gt; (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.stryker.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Stryker&amp;amp;index=3&amp;amp;md5=434f1fb06ba1f087723ea7805934df44&quot; shape=&quot;rect&quot;&gt;Stryker&lt;/a&gt; (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</guid>
   <pubDate>Tue, 19 May 2026 05:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04464118</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216461</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60005111</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02855423</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04998225</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13601934</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13804794</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYK</category>
   	  </item>
  <item>
   <title>BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem</title>
   <link>http://www.streetinsider.com/Press+Releases/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;Three companies with strong roots in the state are revolutionizing the treatment of cardiovascular disease through hydraulic lithotripsy technology&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    CHARLEVOIX, Mich.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.biostarcapital.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=BioStar+Capital&amp;amp;index=1&amp;amp;md5=e4ed4965cb14de744aeaa525f6c4a087&quot; shape=&quot;rect&quot;&gt;BioStar Capital&lt;/a&gt;, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.avspulse.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Amplitude+Vascular+Systems%2C+Inc.&amp;amp;index=2&amp;amp;md5=c8cae98c80cbfdedb6668995e52b1956&quot; shape=&quot;rect&quot;&gt;Amplitude Vascular Systems, Inc.&lt;/a&gt; (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.stryker.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Stryker&amp;amp;index=3&amp;amp;md5=434f1fb06ba1f087723ea7805934df44&quot; shape=&quot;rect&quot;&gt;Stryker&lt;/a&gt; (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</guid>
   <pubDate>Tue, 19 May 2026 05:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04464118</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216461</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60005111</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02855423</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04998225</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13601934</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13804794</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYK</category>
   	  </item>
  <item>
   <title>BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem</title>
   <link>http://www.streetinsider.com/Press+Releases/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;Three companies with strong roots in the state are revolutionizing the treatment of cardiovascular disease through hydraulic lithotripsy technology&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    CHARLEVOIX, Mich.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.biostarcapital.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=BioStar+Capital&amp;amp;index=1&amp;amp;md5=e4ed4965cb14de744aeaa525f6c4a087&quot; shape=&quot;rect&quot;&gt;BioStar Capital&lt;/a&gt;, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.avspulse.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Amplitude+Vascular+Systems%2C+Inc.&amp;amp;index=2&amp;amp;md5=c8cae98c80cbfdedb6668995e52b1956&quot; shape=&quot;rect&quot;&gt;Amplitude Vascular Systems, Inc.&lt;/a&gt; (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.stryker.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Stryker&amp;amp;index=3&amp;amp;md5=434f1fb06ba1f087723ea7805934df44&quot; shape=&quot;rect&quot;&gt;Stryker&lt;/a&gt; (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</guid>
   <pubDate>Tue, 19 May 2026 05:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04464118</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216461</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60005111</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02855423</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04998225</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13601934</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13804794</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYK</category>
   	  </item>
  <item>
   <title>BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem</title>
   <link>http://www.streetinsider.com/Business+Wire/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;Three companies with strong roots in the state are revolutionizing the treatment of cardiovascular disease through hydraulic lithotripsy technology&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    CHARLEVOIX, Mich.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.biostarcapital.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=BioStar+Capital&amp;amp;index=1&amp;amp;md5=e4ed4965cb14de744aeaa525f6c4a087&quot; shape=&quot;rect&quot;&gt;BioStar Capital&lt;/a&gt;, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.avspulse.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Amplitude+Vascular+Systems%2C+Inc.&amp;amp;index=2&amp;amp;md5=c8cae98c80cbfdedb6668995e52b1956&quot; shape=&quot;rect&quot;&gt;Amplitude Vascular Systems, Inc.&lt;/a&gt; (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.stryker.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Stryker&amp;amp;index=3&amp;amp;md5=434f1fb06ba1f087723ea7805934df44&quot; shape=&quot;rect&quot;&gt;Stryker&lt;/a&gt; (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</guid>
   <pubDate>Tue, 19 May 2026 05:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04464118</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216461</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60005111</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02855423</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04998225</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13601934</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13804794</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYK</category>
   	  </item>
  <item>
   <title>BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem</title>
   <link>http://www.streetinsider.com/Business+Wire/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;Three companies with strong roots in the state are revolutionizing the treatment of cardiovascular disease through hydraulic lithotripsy technology&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    CHARLEVOIX, Mich.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.biostarcapital.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=BioStar+Capital&amp;amp;index=1&amp;amp;md5=e4ed4965cb14de744aeaa525f6c4a087&quot; shape=&quot;rect&quot;&gt;BioStar Capital&lt;/a&gt;, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.avspulse.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Amplitude+Vascular+Systems%2C+Inc.&amp;amp;index=2&amp;amp;md5=c8cae98c80cbfdedb6668995e52b1956&quot; shape=&quot;rect&quot;&gt;Amplitude Vascular Systems, Inc.&lt;/a&gt; (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.stryker.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Stryker&amp;amp;index=3&amp;amp;md5=434f1fb06ba1f087723ea7805934df44&quot; shape=&quot;rect&quot;&gt;Stryker&lt;/a&gt; (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</guid>
   <pubDate>Tue, 19 May 2026 05:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04464118</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216461</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60005111</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02855423</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04998225</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13601934</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13804794</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYK</category>
   	  </item>
  <item>
   <title>BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem</title>
   <link>http://www.streetinsider.com/Business+Wire/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;Three companies with strong roots in the state are revolutionizing the treatment of cardiovascular disease through hydraulic lithotripsy technology&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    CHARLEVOIX, Mich.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.biostarcapital.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=BioStar+Capital&amp;amp;index=1&amp;amp;md5=e4ed4965cb14de744aeaa525f6c4a087&quot; shape=&quot;rect&quot;&gt;BioStar Capital&lt;/a&gt;, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.avspulse.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Amplitude+Vascular+Systems%2C+Inc.&amp;amp;index=2&amp;amp;md5=c8cae98c80cbfdedb6668995e52b1956&quot; shape=&quot;rect&quot;&gt;Amplitude Vascular Systems, Inc.&lt;/a&gt; (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.stryker.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Stryker&amp;amp;index=3&amp;amp;md5=434f1fb06ba1f087723ea7805934df44&quot; shape=&quot;rect&quot;&gt;Stryker&lt;/a&gt; (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</guid>
   <pubDate>Tue, 19 May 2026 05:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04464118</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216461</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60005111</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02855423</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04998225</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13601934</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13804794</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYK</category>
   	  </item>
  <item>
   <title>BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem</title>
   <link>http://www.streetinsider.com/Business+Wire/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;Three companies with strong roots in the state are revolutionizing the treatment of cardiovascular disease through hydraulic lithotripsy technology&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    CHARLEVOIX, Mich.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.biostarcapital.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=BioStar+Capital&amp;amp;index=1&amp;amp;md5=e4ed4965cb14de744aeaa525f6c4a087&quot; shape=&quot;rect&quot;&gt;BioStar Capital&lt;/a&gt;, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.avspulse.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Amplitude+Vascular+Systems%2C+Inc.&amp;amp;index=2&amp;amp;md5=c8cae98c80cbfdedb6668995e52b1956&quot; shape=&quot;rect&quot;&gt;Amplitude Vascular Systems, Inc.&lt;/a&gt; (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.stryker.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Stryker&amp;amp;index=3&amp;amp;md5=434f1fb06ba1f087723ea7805934df44&quot; shape=&quot;rect&quot;&gt;Stryker&lt;/a&gt; (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</guid>
   <pubDate>Tue, 19 May 2026 05:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04464118</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216461</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60005111</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02855423</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04998225</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13601934</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13804794</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYK</category>
   	  </item>
  <item>
   <title>BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem</title>
   <link>http://www.streetinsider.com/Business+Wire/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;Three companies with strong roots in the state are revolutionizing the treatment of cardiovascular disease through hydraulic lithotripsy technology&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    CHARLEVOIX, Mich.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.biostarcapital.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=BioStar+Capital&amp;amp;index=1&amp;amp;md5=e4ed4965cb14de744aeaa525f6c4a087&quot; shape=&quot;rect&quot;&gt;BioStar Capital&lt;/a&gt;, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.avspulse.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Amplitude+Vascular+Systems%2C+Inc.&amp;amp;index=2&amp;amp;md5=c8cae98c80cbfdedb6668995e52b1956&quot; shape=&quot;rect&quot;&gt;Amplitude Vascular Systems, Inc.&lt;/a&gt; (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.stryker.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Stryker&amp;amp;index=3&amp;amp;md5=434f1fb06ba1f087723ea7805934df44&quot; shape=&quot;rect&quot;&gt;Stryker&lt;/a&gt; (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</guid>
   <pubDate>Tue, 19 May 2026 05:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04464118</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216461</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60005111</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02855423</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04998225</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13601934</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13804794</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYK</category>
   	  </item>
  <item>
   <title>BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem</title>
   <link>http://www.streetinsider.com/Business+Wire/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;Three companies with strong roots in the state are revolutionizing the treatment of cardiovascular disease through hydraulic lithotripsy technology&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    CHARLEVOIX, Mich.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.biostarcapital.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=BioStar+Capital&amp;amp;index=1&amp;amp;md5=e4ed4965cb14de744aeaa525f6c4a087&quot; shape=&quot;rect&quot;&gt;BioStar Capital&lt;/a&gt;, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.avspulse.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Amplitude+Vascular+Systems%2C+Inc.&amp;amp;index=2&amp;amp;md5=c8cae98c80cbfdedb6668995e52b1956&quot; shape=&quot;rect&quot;&gt;Amplitude Vascular Systems, Inc.&lt;/a&gt; (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.stryker.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Stryker&amp;amp;index=3&amp;amp;md5=434f1fb06ba1f087723ea7805934df44&quot; shape=&quot;rect&quot;&gt;Stryker&lt;/a&gt; (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</guid>
   <pubDate>Tue, 19 May 2026 05:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04464118</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216461</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60005111</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02855423</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04998225</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13601934</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13804794</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYK</category>
   	  </item>
  <item>
   <title>BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem</title>
   <link>http://www.streetinsider.com/Business+Wire/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;Three companies with strong roots in the state are revolutionizing the treatment of cardiovascular disease through hydraulic lithotripsy technology&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    CHARLEVOIX, Mich.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.biostarcapital.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=BioStar+Capital&amp;amp;index=1&amp;amp;md5=e4ed4965cb14de744aeaa525f6c4a087&quot; shape=&quot;rect&quot;&gt;BioStar Capital&lt;/a&gt;, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.avspulse.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Amplitude+Vascular+Systems%2C+Inc.&amp;amp;index=2&amp;amp;md5=c8cae98c80cbfdedb6668995e52b1956&quot; shape=&quot;rect&quot;&gt;Amplitude Vascular Systems, Inc.&lt;/a&gt; (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.stryker.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Stryker&amp;amp;index=3&amp;amp;md5=434f1fb06ba1f087723ea7805934df44&quot; shape=&quot;rect&quot;&gt;Stryker&lt;/a&gt; (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</guid>
   <pubDate>Tue, 19 May 2026 05:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04464118</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216461</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60005111</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02855423</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04998225</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13601934</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13804794</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYK</category>
   	  </item>
  <item>
   <title>BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem</title>
   <link>http://www.streetinsider.com/Business+Wire/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;Three companies with strong roots in the state are revolutionizing the treatment of cardiovascular disease through hydraulic lithotripsy technology&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    CHARLEVOIX, Mich.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.biostarcapital.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=BioStar+Capital&amp;amp;index=1&amp;amp;md5=e4ed4965cb14de744aeaa525f6c4a087&quot; shape=&quot;rect&quot;&gt;BioStar Capital&lt;/a&gt;, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.avspulse.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Amplitude+Vascular+Systems%2C+Inc.&amp;amp;index=2&amp;amp;md5=c8cae98c80cbfdedb6668995e52b1956&quot; shape=&quot;rect&quot;&gt;Amplitude Vascular Systems, Inc.&lt;/a&gt; (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.stryker.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Stryker&amp;amp;index=3&amp;amp;md5=434f1fb06ba1f087723ea7805934df44&quot; shape=&quot;rect&quot;&gt;Stryker&lt;/a&gt; (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</guid>
   <pubDate>Tue, 19 May 2026 05:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04464118</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216461</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60005111</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02855423</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04998225</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13601934</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13804794</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYK</category>
   	  </item>
  <item>
   <title>BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem</title>
   <link>http://www.streetinsider.com/Business+Wire/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</link>
   <description>
&lt;p&gt;
&lt;i&gt;Three companies with strong roots in the state are revolutionizing the treatment of cardiovascular disease through hydraulic lithotripsy technology&lt;/i&gt;

&lt;/p&gt;
&lt;p&gt;    CHARLEVOIX, Mich.--(BUSINESS WIRE)--
&lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.biostarcapital.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=BioStar+Capital&amp;amp;index=1&amp;amp;md5=e4ed4965cb14de744aeaa525f6c4a087&quot; shape=&quot;rect&quot;&gt;BioStar Capital&lt;/a&gt;, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.avspulse.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Amplitude+Vascular+Systems%2C+Inc.&amp;amp;index=2&amp;amp;md5=c8cae98c80cbfdedb6668995e52b1956&quot; shape=&quot;rect&quot;&gt;Amplitude Vascular Systems, Inc.&lt;/a&gt; (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=https%3A%2F%2Fwww.stryker.com%2F&amp;amp;esheet=54537612&amp;amp;newsitemid=20260519752884&amp;amp;lan=en-US&amp;amp;anchor=Stryker&amp;amp;index=3&amp;amp;md5=434f1fb06ba1f087723ea7805934df44&quot; shape=&quot;rect&quot;&gt;Stryker&lt;/a&gt; (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/BioStar+Capital-Backed+Amplitude+Vascular+Systems%E2%80%99+%24835M+Acquisition+by+Stryker+Reflects+Strength+of+Michigan%E2%80%99s+Medtech+Ecosystem/26516345.html</guid>
   <pubDate>Tue, 19 May 2026 05:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04464118</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50216461</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.60005111</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02855423</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.04998225</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13601934</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.13804794</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SYK</category>
   	  </item>
  <item>
   <title>IMPULSE DYNAMICS APPOINTS FIVE NEW BOARD MEMBERS</title>
   <link>http://www.streetinsider.com/Press+Releases/IMPULSE+DYNAMICS+APPOINTS+FIVE+NEW+BOARD+MEMBERS/19201080.html</link>
   <description>si-local-file:///var/storage/newsbody/2021/1111/19201080.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/IMPULSE+DYNAMICS+APPOINTS+FIVE+NEW+BOARD+MEMBERS/19201080.html</guid>
   <pubDate>Thu, 11 Nov 2021 19:26:31 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CYBX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ENTL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GMED</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GMED</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GTHX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HDIX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HOLX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RGEN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RWLK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TMCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TMDX</category>
   	  </item>
  <item>
   <title>IMPULSE DYNAMICS APPOINTS FIVE NEW BOARD MEMBERS</title>
   <link>http://www.streetinsider.com/Press+Releases/IMPULSE+DYNAMICS+APPOINTS+FIVE+NEW+BOARD+MEMBERS/19201080.html</link>
   <description>si-local-file:///var/storage/newsbody/2021/1111/19201080.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/IMPULSE+DYNAMICS+APPOINTS+FIVE+NEW+BOARD+MEMBERS/19201080.html</guid>
   <pubDate>Thu, 11 Nov 2021 19:26:31 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CYBX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ENTL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GMED</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GMED</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GTHX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HDIX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HOLX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RGEN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RWLK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TMCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TMDX</category>
   	  </item>
  <item>
   <title>IMPULSE DYNAMICS APPOINTS FIVE NEW BOARD MEMBERS</title>
   <link>http://www.streetinsider.com/Press+Releases/IMPULSE+DYNAMICS+APPOINTS+FIVE+NEW+BOARD+MEMBERS/19201080.html</link>
   <description>si-local-file:///var/storage/newsbody/2021/1111/19201080.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/IMPULSE+DYNAMICS+APPOINTS+FIVE+NEW+BOARD+MEMBERS/19201080.html</guid>
   <pubDate>Thu, 11 Nov 2021 19:26:31 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CYBX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ENTL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GMED</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GMED</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GTHX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HDIX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HOLX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RGEN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RWLK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TMCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TMDX</category>
   	  </item>
  <item>
   <title>IMPULSE DYNAMICS APPOINTS FIVE NEW BOARD MEMBERS</title>
   <link>http://www.streetinsider.com/Press+Releases/IMPULSE+DYNAMICS+APPOINTS+FIVE+NEW+BOARD+MEMBERS/19201080.html</link>
   <description>si-local-file:///var/storage/newsbody/2021/1111/19201080.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/IMPULSE+DYNAMICS+APPOINTS+FIVE+NEW+BOARD+MEMBERS/19201080.html</guid>
   <pubDate>Thu, 11 Nov 2021 19:26:31 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CYBX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ENTL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GMED</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GMED</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GTHX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HDIX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HOLX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RGEN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RWLK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TMCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TMDX</category>
   	  </item>
  <item>
   <title>IMPULSE DYNAMICS APPOINTS FIVE NEW BOARD MEMBERS</title>
   <link>http://www.streetinsider.com/Press+Releases/IMPULSE+DYNAMICS+APPOINTS+FIVE+NEW+BOARD+MEMBERS/19201080.html</link>
   <description>si-local-file:///var/storage/newsbody/2021/1111/19201080.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/IMPULSE+DYNAMICS+APPOINTS+FIVE+NEW+BOARD+MEMBERS/19201080.html</guid>
   <pubDate>Thu, 11 Nov 2021 19:26:31 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CYBX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ENTL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GMED</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GMED</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GTHX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HDIX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HOLX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RGEN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RWLK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TMCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TMDX</category>
   	  </item>
  <item>
   <title>IMPULSE DYNAMICS APPOINTS FIVE NEW BOARD MEMBERS</title>
   <link>http://www.streetinsider.com/Press+Releases/IMPULSE+DYNAMICS+APPOINTS+FIVE+NEW+BOARD+MEMBERS/19201080.html</link>
   <description>si-local-file:///var/storage/newsbody/2021/1111/19201080.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/IMPULSE+DYNAMICS+APPOINTS+FIVE+NEW+BOARD+MEMBERS/19201080.html</guid>
   <pubDate>Thu, 11 Nov 2021 19:26:31 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CYBX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ENTL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GMED</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GMED</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GTHX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HDIX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HOLX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RGEN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RWLK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TMCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TMDX</category>
   	  </item>
  <item>
   <title>IMPULSE DYNAMICS APPOINTS FIVE NEW BOARD MEMBERS</title>
   <link>http://www.streetinsider.com/Press+Releases/IMPULSE+DYNAMICS+APPOINTS+FIVE+NEW+BOARD+MEMBERS/19201080.html</link>
   <description>si-local-file:///var/storage/newsbody/2021/1111/19201080.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/IMPULSE+DYNAMICS+APPOINTS+FIVE+NEW+BOARD+MEMBERS/19201080.html</guid>
   <pubDate>Thu, 11 Nov 2021 19:26:31 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CVRS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CYBX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ENTL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GMED</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GMED</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GTHX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HDIX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HOLX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RGEN</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">RWLK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TMCI</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">TMDX</category>
   	  </item>
 </channel>
</rss>
